ALIREZA ABIDI, M.D.
Gynecologic Oncology Physician in SACRAMENTO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: ALIREZA ABIDI, M.D. filed 637 Medicare Part D claims in 2023 across SACRAMENTO, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
ALIREZA ABIDI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
ALIREZA ABIDI, M.D. at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Gynecologic Oncology Physician compares to other specialties among California providers
Gynecologic Oncology Physician share within California
Gynecologic Oncology Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Gynecologic Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Gynecologic Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Gynecologic Oncology Physician US NPIs
Specialty board-certified rate — Gynecologic Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ALIREZA ABIDI, M.D. is a Gynecologic Oncology Physician provider practicing in SACRAMENTO, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1215919477. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
ALIREZA ABIDI, M.D. appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding M.D. credentials at 4860 Y ST, SACRAMENTO, CA, 95817, with a listed phone of (916) 734-6930. NPI 1215919477 was issued on 11/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABIDI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 637 prescription claims written by this provider, covering 164 Medicare beneficiaries and totaling roughly $431K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 4.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1215919477 |
|---|---|
| Specialty | Gynecologic Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/15/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ALIREZA ABIDI, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ALIREZA ABIDI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ALIREZA ABIDI, M.D.. To verify ALIREZA ABIDI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 637 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,125
- Total Day Supply
- 27,668
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $411K
- Generic Drug Cost
- $19K
- Opioid Claims
- 29 (4.6% rate)
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.46
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Anastrozole | 95 |
| Estradiol | 55 |
| Ondansetron Hcl | 36 |
| Dexamethasone | 35 |
| Letrozole | 34 |
| Gabapentin | 33 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 18 |
| Zejula Niraparib Tosylate | 18 |
| Clobetasol Propionate | 17 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gynecologic Oncology Physician Overview
How ALIREZA ABIDI, M.D. fits within the Gynecologic Oncology Physician landscape nationally.
ALIREZA ABIDI, M.D.'s 637 claims are above the specialty average of 188.
Nearby Gynecologic Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ABIDI.
Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is ALIREZA ABIDI, M.D.'s specialty? ▼
How much does ALIREZA ABIDI, M.D. prescribe under Medicare Part D? ▼
Where is ALIREZA ABIDI, M.D. located? ▼
What is ALIREZA ABIDI, M.D.'s NPI number? ▼
Does ALIREZA ABIDI, M.D. prescribe more brand-name or generic drugs? ▼
Does ALIREZA ABIDI, M.D. prescribe opioids? ▼
How many Gynecologic Oncology Physician providers are there in the US? ▼
What drugs does ALIREZA ABIDI, M.D. prescribe most often? ▼
Does ALIREZA ABIDI, M.D. accept Medicare? ▼
How can I verify ALIREZA ABIDI, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology